The journey of Tanishi Lifescience, a culmination of a dream of a young visionary industrialist, began in 2017 with a concept to produce the best quality medicines at the most affordable prices with innovations and make strong presence not only in domestic market but as well as in global scenarios. As part of business conglomerate which has varied business interest, cutting across continents, Tanishi Lifescience entered into Indian
A New Phase of Growth
The dexterous team at Tanishi Lifescience believes in adding to quality of life by dis-covering, developing, and marketing pharma products that meet the needs of their customers. Also, the company plays a pivotal role in alleviating the human sufferings through its quality, innovative and affordable medicines. "We at Tanishi always believe to design such brands to ease the pain and discomforts of patients to meet prescription demand of prescribers' so as to improve confidence among medical fraternity as well as of patients," he says. The company aims to strengthen its presence further in therapeutic segments like Anti-bacterial, Anti-inflammatory, Analgesics, Nutritional, Cardiology and Diabetology by introducing new, improved molecules and dosage forms. "To strengthen our port-folio further we are in touch with our manufacturers to bring newly advance molecules with dosage advantages & least interactions. Indian pharmaceutical industries always welcome newer molecules & existing drugs combination to meet the requirements of prescribers. We are also working towards introducing products in new therapeutic segments to broaden our base," he informs.
Since inception, Tanishi Lifescience has strived to create a strong foothold in the industry. It is thoroughly and incessantly trying to improve its presence through its innovative products' portfolio to serve its customers. "Since the beginning of our inception, we planned our strategies in such a way so that align with our objectives, earn profits, cater quality to the clients and focus on organisational growth & expansion. Our endeavour is to improve quality of life through molecular and biological benefits," he adds.
In the coming years, the company aims to improve sales of each and every individual brand as well increase coverage by inducting fresh field force and opening new headquarters across India. "Our long-term goal is to step ahead from a small entrepreneurial life science pharma company to global corporation. We aim to achieve increased performance by improving efficacy and effectiveness of company key business operation," he concludes.